Accéder au contenu
Merck

The increased marginal zone B cells attenuates early inflammatory responses during sepsis in Gpr174 deficient mice.

International immunopharmacology (2019-12-02)
Ming Zhu, Chong Li, Zhenju Song, Sucheng Mu, Jianli Wang, Wei Wei, Yi Han, Dongze Qiu, Xun Chu, Chaoyang Tong
RÉSUMÉ

GPR174 plays a crucial role in immune responses, but the role of GPR174 in the pathological progress of sepsis remains incompletely understood. In this study, we generated a sepsis model by cecal ligation and puncture (CLP) to investigate the role of GPR174 in regulating functions and underlying mechanism of marginal zone B (MZ B) cells in sepsis. We found that in Gpr174 deficient mice, the number of splenic MZ B cells was increased. Moreover, Gpr174-/- MZ B cells exhibited an enhanced response to LPS stimulation in vitro. By using the CLP-induced sepsis model, we demonstrated that the increased MZ B cells attenuated early inflammatory responses during sepsis. RNA sequencing results revealed that the expression of c-fos in splenic B lymphocytes was upregulated in Gpr174 deficient mice. However, the protective role of increased MZ B cells in Gpr174 deficient mice was weakened by a c-fos-specific inhibitor. Collectively, these findings suggested that GPR174 plays an immunomodulatory role in early immune responses during sepsis through the regulation of MZ B cells.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
2,2,2-Tribromoethanol, 97%
Avanti
18:0 Lyso PS, 1-stearoyl-2-hydroxy-sn-glycero-3-phospho-L-serine (sodium salt), powder